118 related articles for article (PubMed ID: 23870412)
1. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder.
Liu JY; Li YH; Lin HX; Liao YJ; Mai SJ; Liu ZW; Zhang ZL; Jiang LJ; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
BMC Cancer; 2013 Jul; 13():349. PubMed ID: 23870412
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma.
Li J; Sheng C; Li W; Zheng JH
Int J Clin Exp Pathol; 2014; 7(3):1147-53. PubMed ID: 24696731
[TBL] [Abstract][Full Text] [Related]
3. Hedgehog pathway activation in human transitional cell carcinoma of the bladder.
Pignot G; Vieillefond A; Vacher S; Zerbib M; Debre B; Lidereau R; Amsellem-Ouazana D; Bieche I
Br J Cancer; 2012 Mar; 106(6):1177-86. PubMed ID: 22361633
[TBL] [Abstract][Full Text] [Related]
4. Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder.
Piyarathna DWB; Rajendiran TM; Putluri V; Vantaku V; Soni T; von Rundstedt FC; Donepudi SR; Jin F; Maity S; Ambati CR; Dong J; Gödde D; Roth S; Störkel S; Degener S; Michailidis G; Lerner SP; Pennathur S; Lotan Y; Coarfa C; Sreekumar A; Putluri N
Eur Urol Focus; 2018 Dec; 4(6):907-915. PubMed ID: 28753886
[TBL] [Abstract][Full Text] [Related]
5. Potential Value of YAP Staining in Rhabdomyosarcoma.
Ahmed AA; Habeebu SS; Sherman AK; Ye SQ; Wood N; Chastain KM; Tsokos MG
J Histochem Cytochem; 2018 Aug; 66(8):577-584. PubMed ID: 29596030
[TBL] [Abstract][Full Text] [Related]
6. Expressions and Clinical Significance of Met and YAP in Gastric Cancer Tissue Microarray.
Li J; Zhang X; Liu Y; Zhou J; Shen L; Yue G
Gastroenterol Res Pract; 2024; 2024():5591298. PubMed ID: 38634107
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Citron Rho-Interacting Serine/Threonine Kinase Associated with Poor Outcome in Bladder Cancer.
Shou J; Yu C; Zhang D; Zhang Q
J Cancer; 2020; 11(14):4173-4180. PubMed ID: 32368300
[No Abstract] [Full Text] [Related]
8. YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer.
Bencivenga M; Torroni L; Dal Cero M; Quinzii A; Zecchetto C; Merz V; Casalino S; Taus F; Pietrobono S; Mangiameli D; Filippini F; Alloggio M; Castelli C; Iglesias M; Pera M; Melisi D
J Pers Med; 2023 Aug; 13(9):. PubMed ID: 37763062
[TBL] [Abstract][Full Text] [Related]
9. Expression of TMEM40 in bladder cancer and its correlation with clinicopathological parameters.
Zhang QY; Fu MT; Zhang ZF; Feng YZ; Wei M; Zhou JY; Shi R
Int J Clin Exp Pathol; 2017; 10(7):8050-8057. PubMed ID: 31966657
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.
Latz S; Umbach T; Goltz D; Kristiansen G; Müller SC; Ellinger J
Urol Int; 2016; 96(1):39-45. PubMed ID: 26287745
[TBL] [Abstract][Full Text] [Related]
11. Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer.
Jeong W; Kim SB; Sohn BH; Park YY; Park ES; Kim SC; Kim SS; Johnson RL; Birrer M; Bowtell DSL; Mills GB; Sood A; Lee JS
Anticancer Res; 2014 Feb; 34(2):811-817. PubMed ID: 24511017
[TBL] [Abstract][Full Text] [Related]
12. YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function.
Tsutsumi R; Masoudi M; Takahashi A; Fujii Y; Hayashi T; Kikuchi I; Satou Y; Taira M; Hatakeyama M
Dev Cell; 2013 Sep; 26(6):658-65. PubMed ID: 24035415
[TBL] [Abstract][Full Text] [Related]
13. YAP1 and P53 Expression in Papillary Thyroid Carcinoma.
Abdelhafez DN; Ayoub MM; Mahmoud SA; El Hanbuli HM
Iran J Pathol; 2023; 18(1):49-56. PubMed ID: 37383164
[TBL] [Abstract][Full Text] [Related]
14. Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro.
Pettitt GA; Hurst CD; Khan Z; McPherson HR; Dunning MC; Alder O; Platt FM; Black EV; Burns JE; Knowles MA
J Pathol; 2023 Feb; 259(2):220-232. PubMed ID: 36385700
[TBL] [Abstract][Full Text] [Related]
15. Targeting Transcription Factors in Cancer: From "Undruggable" to "Druggable".
Tao Z; Wu X
Methods Mol Biol; 2023; 2594():107-131. PubMed ID: 36264492
[TBL] [Abstract][Full Text] [Related]
16. TEAD4 as an Oncogene and a Mitochondrial Modulator.
Hsu SC; Lin CY; Lin YY; Collins CC; Chen CL; Kung HJ
Front Cell Dev Biol; 2022; 10():890419. PubMed ID: 35602596
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Yes-Associated Protein-1 (YAP1) Target Gene Signature to Predict Progressive Breast Cancer.
Venkatasubramanian G; Kelkar DA; Mandal S; Jolly MK; Kulkarni M
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407556
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA LONP2 regulates proliferation, invasion, and apoptosis of bladder cancer cells by sponging microRNA-584-5p.
Zhang X; Xiong H; Zhao Y; Lin S; Huang X; Lin C; Mao S; Chen D
Bioengineered; 2022 Apr; 13(4):8823-8835. PubMed ID: 35358000
[TBL] [Abstract][Full Text] [Related]
19. DAB2 suppresses gastric cancer migration by regulating the Wnt/β-catenin and Hippo-YAP signaling pathways.
Wang H; Dong S; Liu Y; Ma F; Fang J; Zhang W; Shao S; Shen H; Jin J
Transl Cancer Res; 2020 Feb; 9(2):1174-1184. PubMed ID: 35117462
[TBL] [Abstract][Full Text] [Related]
20. Expression of
Cheng Y; Huang H; Han Y; Zhu Y
Transl Cancer Res; 2020 Nov; 9(11):7248-7258. PubMed ID: 35117328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
